Researchers built a polygenic risk score from a more diverse database, improving estimates for people often underrepresented ...
One of USC Epstein Family Alzheimer’s Therapeutic Research Institute (ATRI) key scientists, Michael Rafii, is behind a new ...
An MRI-defined pattern of cortical atrophy may help identify patients with early-onset Alzheimer’s disease at risk for more ...
One vial of blood could provide an important clue about what’s happening inside the brain. The FDA has cleared ELECSYS ...
The Food and Drug Administration (FDA) has granted approval for a new test for Alzheimer’s disease, marking the fourth time ...
The FDA approved Roche Diagnostics and Eli Lilly’s blood test to help doctors assess Alzheimer’s disease in people 55 and ...
The next episode in this series, 'Empowering Primary Care: Early Alzheimer's Detection and the Referral Pathway Challenge,' features the panelists advancing their conversation on Alzheimer's disease ...
Dr. Ian Grant, behavioral neurologist at Northwestern Medicine’s Cognitive Neurology & Alzheimer’s Disease Center, joins Bob ...
Two University of Wyoming faculty members will further their research in understanding the microcircuit changes that occur in ...
The adult human brain has limited capacity to repair or regenerate neurons lost to Alzheimer's disease, the most common type of dementia. Existing treatments can slow disease progression but do not ...
Late-onset Alzheimer's disease (AD) is a progressive disorder characterized by cognitive decline and memory impairment, ...
In this episode titled, 'Alzheimer's Disease Prevalence and Prevention: Building the Case for Early Diagnosis,' Kavita Nair, PhD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results